Section Arrow
PCVX.NASDAQ
- Vaxcyte
Quotes are at least 15-min delayed:2026/11/04 17:03 EST
After Hours
Last
 62.0868
-3.5932 (-5.47%)
Bid
61.91
Ask
69.44
High 65.75 
Low 62.0868 
Volume 88.63K 
Regular Hours (Closed)
Last
 65.68
+4.87 (+8.01%)
Day High 
65.71 
Prev. Close
60.81 
1-M High
90.75 
Volume 
2.24M 
Bid
61.91
Ask
69.44
Day Low
60.04 
Open
62.87 
1-M Low
59.19 
Market Cap 
9.57B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 61.47 
20-SMA 64.09 
50-SMA 61.54 
52-W High 90.75 
52-W Low 41.435 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.63/-4.44
Enterprise Value
9.68B
Balance Sheet
Book Value Per Share
17.52
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.11+0.3961+55.48%0.2PE
After Hours 1.04 -0.07 -6.31%
KPTIKaryopharm Therapeutics Inc.0.0729-0.0154-17.44%-- 
After Hours 0.0761 +0.0032 +4.39%
GERNGeron Corp1.08+0.15+16.13%-- 
After Hours 1.07 -0.01 -0.93%
INOInovio Pharmaceuticals1.62-0.04-2.41%-- 
After Hours 1.6115 -0.0085 -0.52%
RXRXRecursion Pharmaceuticals3.88+0.2+5.43%-- 
After Hours 3.8608 -0.0192 -0.49%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.